Global Tissue Engineering Market to Reach $50 Billion by 2030
The global market for Tissue Engineering estimated at US$16.1 Billion in the year 2022, is projected to reach a revised size of US$50 Billion by 2030, growing at a CAGR of 15.2% over the analysis period 2022-2030. Orthopedics, Musculoskeletal & Spine, one of the segments analyzed in the report, is projected to record 12.5% CAGR and reach US$11.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Cardiology & Vascular segment is readjusted to a revised 18.5% CAGR for the next 8-year period.The U.S. Market is Estimated at $4.7 Billion, While China is Forecast to Grow at 14.8% CAGR
The Tissue Engineering market in the U.S. is estimated at US$4.7 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$8.7 Billion by the year 2030 trailing a CAGR of 14.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.9% and 13.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 11.3% CAGR.Select Competitors (Total 49 Featured) -
- Acelity L.P. Inc.
- Advanced Cell Technology
- Allergan Plc
- Arteriocyte
- Athersys
- Baxter International Inc
- BioMimetic Therapeutics
- Cook Biotech Inc.
- CryoLife
- DePuy Synthes (Johnson & Johnson Services, Inc.)
- Integra Life Sciences Corporation
- LifeCell Kinetic Concepts
- Medtronic
- Organogenesis Inc.
- RTI surgical
- Sanofi
- StemCells, Inc.
- Stryker Corporation
- Zimmer Biomet
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
REST OF EUROPE
ASIA-PACIFIC
REST OF WORLD
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Acelity L.P. Inc.
- Advanced Cell Technology
- Allergan Plc
- Arteriocyte
- Athersys
- Baxter International Inc
- BioMimetic Therapeutics
- Cook Biotech Inc.
- CryoLife
- DePuy Synthes (Johnson & Johnson Services, Inc.)
- Integra Life Sciences Corporation
- LifeCell Kinetic Concepts
- Medtronic
- Organogenesis Inc.
- RTI surgical
- Sanofi
- StemCells, Inc.
- Stryker Corporation
- Zimmer Biomet
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 97 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 16.1 Billion |
Forecasted Market Value ( USD | $ 50 Billion |
Compound Annual Growth Rate | 15.2% |
Regions Covered | Global |